Form 8-K - Current report:
SEC Accession No. 0000950170-24-127067
Filing Date
2024-11-14
Accepted
2024-11-14 16:12:40
Documents
12
Period of Report
2024-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pstv-20241114.htm   iXBRL 8-K 44119
2 EX-99.1 pstv-ex99_1.htm EX-99.1 308090
  Complete submission text file 0000950170-24-127067.txt   491179

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pstv-20241114.xsd EX-101.SCH 30909
14 EXTRACTED XBRL INSTANCE DOCUMENT pstv-20241114_htm.xml XML 4708
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 241462318
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)